Pulmonary fibrosis is classified as a restrictive lung disease. The scarring that defines the condition stiffens the lungs and shrinks their usable volume, making it harder to take a full breath in rather than harder to push air out. That said, the real-world picture is not always so clean: some people with pulmonary fibrosis also have emphysema or small-airway changes that introduce obstructive features, and the overlap can mask how severe either problem actually is.
What Makes It Restrictive
In a healthy lung, the tissue surrounding the air sacs is stretchy, rich in a protein called elastin, which lets the lungs expand easily during a breath. In pulmonary fibrosis, repeated cycles of microscopic injury to the lining of the air sacs trigger a repair response that overshoots. Fibroblasts multiply and lay down dense, stiff collagen where the flexible matrix used to be.1PubMed Central. Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis The result is a lung that resists stretching. It still lets air flow through the airways without much obstruction, but there is simply less room for air and less ability to inflate.
This stiffening is what doctors mean by reduced lung compliance. The chest wall itself stays roughly normal in strength and flexibility, so the restriction is really about the lung tissue itself becoming rigid.2European Respiratory Review. Physiology of the lung in idiopathic pulmonary fibrosis Think of trying to blow up a new balloon versus a hardened, sun-baked one: the air can get in, but only so much, and it takes more effort. That is essentially what happens when fibrosis replaces normal lung tissue with scar.
How Lung Function Tests Show the Difference
When you blow into a spirometer, two numbers matter most for sorting out restriction versus obstruction. The first is forced vital capacity (FVC), which is the total amount of air you can push out after the deepest breath possible. The second is the ratio of how much air comes out in the first second (FEV1) to that total (FEV1/FVC). In obstructive diseases like COPD or asthma, the airways narrow and slow the outflow, so FEV1 drops and the ratio falls below normal. In a restrictive disease like pulmonary fibrosis, both FEV1 and FVC shrink because the lungs simply hold less air, but the ratio stays normal or even rises because whatever air is present comes out quickly through airways that are not blocked.3BMJ Publishing Group / Respiratory Research. Impulse oscillometry and traditional pulmonary function testing: correlation, advances and clinical implications
Spirometry alone, though, can only suggest restriction. The gold standard for confirming it is body plethysmography, which measures total lung capacity (TLC) while you sit inside a sealed booth. A TLC below the lower limit of normal confirms that the lungs are genuinely smaller, not just that the person didn’t blow hard enough. One study of interstitial lung disease patients found that spirometry’s sensitivity for detecting true volume restriction (as confirmed by TLC) was about 69%, with a positive predictive value near 89%.4Respiration / S. Karger AG. Value of Spirometry in Detecting Volume Restriction in Interstitial Lung Disease Patients: Spirometry in Interstitial Lung Diseases In other words, spirometry catches most cases but misses some, so plethysmography remains important when the diagnosis is uncertain.
The Gas Exchange Problem
Restriction tells only part of the story. Pulmonary fibrosis also wrecks the lung’s ability to transfer oxygen from the air sacs into the bloodstream, a measurement captured by the diffusing capacity for carbon monoxide (DLCO). Scarring thickens the barrier between air and blood, and fibrosis destroys many of the tiny capillaries that normally participate in gas exchange. The result is that even when enough air gets into the lungs, oxygen does not cross efficiently.
This matters most during exercise. At rest, the remaining healthy lung tissue can sometimes compensate well enough that blood oxygen levels stay acceptable. But when the heart pumps faster and blood rushes through the lungs more quickly, there is not enough time or surface area for adequate oxygen transfer. In patients with fibrosing alveolitis, diffusion limitation accounted for virtually all of the gap between expected and actual blood oxygen levels during exercise.5Respiration Physiology. DlCO/Q̇ and diffusion limitation at rest and on exercise in patients with interstitial fibrosis This is why people with pulmonary fibrosis often feel fine sitting down but become severely breathless walking across a room or climbing stairs.
How Breathing Changes During Exercise
Healthy people respond to exercise by taking deeper breaths. People with pulmonary fibrosis cannot do that because their stiff lungs resist expansion, so they compensate by breathing faster instead. The pattern is rapid and shallow: small breaths at a high rate. Their total ventilation goes up, but it is driven almost entirely by breathing frequency rather than by deeper inhalations.6European Respiratory Review. Exertional dyspnoea in interstitial lung diseases: the clinical utility of cardiopulmonary exercise testing This rapid shallow pattern is less efficient at getting fresh air to the gas-exchange regions of the lungs, which compounds the diffusion problem described above and helps explain why exercise tolerance drops so dramatically.
When Fibrosis and Emphysema Coexist
Here is where the clean “restrictive” label starts to mislead. A significant number of people, especially former or current smokers, develop both pulmonary fibrosis and emphysema at the same time. This combination, known as combined pulmonary fibrosis and emphysema (CPFE), creates a tug-of-war on lung function tests. Emphysema destroys lung tissue and makes the lungs hyperinflated and floppy, which inflates lung volumes. Fibrosis does the opposite, stiffening and shrinking the lungs. When these two effects cancel each other out, spirometry and lung volumes can look nearly normal, even though the lungs are profoundly damaged.7Mayo Clinic Proceedings. Combined Pulmonary Fibrosis and Emphysema: A Review
The giveaway in CPFE is the DLCO, which drops severely because both diseases destroy gas-exchange surfaces. Lung volumes may appear preserved, airflow ratios may look acceptable, but the DLCO is devastated. Patients typically experience severe shortness of breath on exertion and are at high risk for pulmonary hypertension, which worsens the prognosis considerably.8European Respiratory Journal. Combined pulmonary fibrosis and emphysema syndrome: the age of majority On a chest CT scan, the pattern is usually distinct: emphysema in the upper portions of the lungs and fibrosis in the lower lobes, with honeycombing and traction bronchiectasis visible in the scarred areas.9Mayo Clinic Proceedings. Combined Pulmonary Fibrosis and Emphysema: A Review – Section: Chest Imaging
The practical danger of CPFE is underdiagnosis. A doctor who sees relatively normal spirometry and lung volumes might be falsely reassured. Only when the DLCO is checked, or a CT scan is ordered, does the true extent of lung damage become clear. If you have a smoking history and worsening breathlessness but your spirometry “looks okay,” it is worth asking whether both processes could be at play.
Small Airway Changes That Blur the Line
Even without full-blown emphysema, pulmonary fibrosis can affect the small airways in ways that would not show up on standard spirometry. Research using micro-CT imaging of lung tissue from people with idiopathic pulmonary fibrosis (IPF) has found that the number of terminal and transitional bronchioles is reduced and the walls of the remaining small airways are thickened, even in areas of the lung that do not yet show visible scarring.10American Journal of Respiratory and Critical Care Medicine. Small Airway Reduction and Fibrosis Is an Early Pathologic Feature of Idiopathic Pulmonary Fibrosis This suggests that small-airway disease may be one of the earliest events in fibrosis, not just a downstream consequence of advanced scarring.
A newer technique called oscillometry can pick up on these small-airway changes by measuring resistance and reactance in the lung during normal, quiet breathing, without requiring the forced breathing maneuvers of spirometry. Studies have found that oscillometry detects increased peripheral resistance in fibrosis patients, reflecting the small-airway pathology that spirometry misses.11PubMed Central. Oscillometry Assesses Small Airway Disease and Reveals Peripheral Lung Pathology in Early Pulmonary Fibrosis: A Cross-Sectional Study This does not mean fibrosis suddenly becomes an obstructive disease. It means the traditional binary classification oversimplifies what is actually happening in the lungs. The dominant pattern remains restrictive, but there are obstructive elements simmering underneath in many patients.
Traction Bronchiectasis and Airway Distortion
As fibrosis progresses, the scar tissue physically pulls on the airways around it, stretching them open in an abnormal way. This is called traction bronchiectasis, and it is visible on CT scans as dilated, irregular airways surrounded by fibrotic lung. You might assume that stretched-open airways would make airflow easier, but the distortion actually disrupts normal airflow patterns and contributes to inefficient ventilation. In one study, the severity of traction bronchiectasis was independently linked to worse DLCO, lower FVC, and lower blood oxygen levels, though not to standard measures of airflow obstruction.12PubMed. Traction bronchiectasis in cryptogenic fibrosing alveolitis: associated computed tomographic features and physiological significance So traction bronchiectasis worsens function without technically creating the kind of obstruction seen in asthma or COPD. It is another example of how the simple restrictive-versus-obstructive dichotomy falls short of capturing the full damage fibrosis does to the lungs.
Tracking Disease Progression
Because pulmonary fibrosis is progressive, monitoring how quickly lung function declines is central to clinical decision-making. The most widely used marker is the FVC, measured at regular intervals. A drop in FVC of 10% or more over six months is considered clinically significant and is associated with worse survival.13European Respiratory Review. Evaluating disease severity in idiopathic pulmonary fibrosis This threshold is also the primary endpoint used in clinical trials for antifibrotic drugs.
FVC decline as a surrogate for disease progression is not without controversy. Some researchers have pointed out that FVC has not been fully validated as a surrogate endpoint for mortality in IPF, since there is no therapy that dramatically improves survival to use as a benchmark.14European Respiratory Review. Exploring the 175-year history of spirometry and the vital lessons it can teach us today Newer approaches using serial CT scans to quantify changes in lung density and volume may add prognostic information beyond what FVC alone provides. One study found that CT-derived measures of lung density change predicted mortality even when FVC decline did not reach the 10% threshold.15PubMed Central. Serial Decline in Lung Volume Parameters on Computed Tomography (CT) Predicts Outcome in Idiopathic Pulmonary Fibrosis (IPF) For now, though, FVC remains the standard tracking tool in most clinics.
When Obesity Compounds the Restriction
Obesity creates its own form of restrictive physiology by loading weight onto the chest wall and diaphragm, reducing lung expansion even in people without lung disease. When someone with pulmonary fibrosis is also overweight or obese, those two restrictive forces stack up. Research has shown that overweight and obese patients with fibrotic interstitial lung disease had worse pulmonary function, worse exercise capacity, more breathlessness, and lower quality of life compared to normal-weight patients with the same diagnosis.16PubMed. Association of BMI with pulmonary function, functional capacity, symptoms, and quality of life in ILD
The encouraging flipside is that weight loss in this population appears to help. A study of obese interstitial lung disease patients who lost weight found significant improvements in FVC, functional residual capacity, and DLCO, with a strong correlation between the amount of weight lost and the improvement in FVC.17PubMed. Beneficial impact of weight loss on respiratory function in interstitial lung disease patients with obesity This does not reverse the fibrosis itself, but it removes an additional mechanical burden on lungs that are already struggling to expand. Weight management is one of the few areas where patients have direct control over a factor that measurably affects their lung function.
Pulmonary Fibrosis in Children
Pulmonary fibrosis is rare in children, but it does occur, and the physiology follows the same restrictive pattern. A study of 65 pediatric patients aged 5 to 20 with idiopathic interstitial pulmonary fibrosis found that vital capacity was significantly reduced in every patient. Total lung capacity was reduced in 91%, static compliance was reduced in 83%, and dynamic compliance in 88%. Elastic recoil of the lungs was significantly increased in 97% of patients, reflecting the same stiffening seen in adults.18PubMed. Lung function in children and adolescents with idiopathic interstitial pulmonary fibrosis These numbers reinforce that the restrictive defect is intrinsic to the fibrotic process regardless of the patient’s age. The additional concern in children is the potential impact on lung growth and development during a period when the lungs would normally be gaining volume and surface area.
Other Interstitial Diseases and the Obstruction Question
Pulmonary fibrosis is the most common interstitial lung disease, but it is not the only one, and some of its relatives can cause airway obstruction in addition to or instead of restriction. Sarcoidosis, for instance, can produce granulomas along the airways that trap air and create obstructive physiology. CT imaging of sarcoidosis patients commonly shows air trapping, which is a hallmark of airway obstruction, across all stages of the disease.19PubMed. Airways obstruction in patients with sarcoidosis: expiratory CT scan findings Hypersensitivity pneumonitis, another interstitial lung disease caused by inhaled allergens, can also show air trapping alongside the fibrotic changes.20PubMed. Hypersensitivity pneumonitis: a historical, clinical, and radiologic review
These examples matter because “interstitial lung disease” is a broad umbrella, and not everything under it behaves the same way on pulmonary function tests. If you have been told you have an interstitial lung disease and your spirometry shows obstructive features, it does not necessarily mean the diagnosis is wrong. It may mean you have one of the subtypes where airway involvement is part of the picture, or that a second process like coexisting COPD or asthma is contributing. The key is that idiopathic pulmonary fibrosis itself, the most common and most-discussed form, is overwhelmingly restrictive in its dominant physiology.